Table 3.
IVS hypertrophy for the prediction of CHD, MI and stroke during follow up.
| Subgroups | CHD | MI | ||||
|---|---|---|---|---|---|---|
| Cases/Noncases | Incidence HR (95% CI) | p Value | Case/Noncases | Incidence HR (95% CI) | p Value | |
| Before Adjustment | ||||||
| Overall | ||||||
| Normal IVSd | 120/4299 | Reference | / | 51/4368 | Reference | / |
| IVS hypertrophy | 26/356 | 2.757 (1.802–4.219) | <0.001 | 16/366 | 4.157 (2.357–7.332) | <0.001 |
| Male | ||||||
| Normal IVSd | 46/2130 | Reference | / | 22/2154 | Reference | / |
| IVS hypertrophy | 9/148 | 2.893 (1.414–5.917) | 0.004 | 4/153 | 2.732 (0.938–7.96) | 0.065 |
| Female | ||||||
| Normal IVSd | 74/2169 | Reference | / | 29/2214 | Reference | / |
| IVS hypertrophy | 17/208 | 2.558 (1.507–4.344) | <0.001 | 12/213 | 4.951(2.497–9.817) | <0.001 |
| After Adjustment | ||||||
| Overall | ||||||
| Normal IVSd | 120/4299 | Reference | / | 51/4368 | Reference | / |
| IVS hypertrophy | 26/356 | 1.818 (1.155–2.816) | 0.01 | 16/366 | 2.410 (1.303–4.458) | 0.005 |
| Male | ||||||
| Normal IVSd | 46/2130 | Reference | / | 22/2154 | Reference | / |
| IVS hypertrophy | 9/148 | 1.873 (0.875–4.008) | 0.106 | 4/153 | 1.639 (0.516–5.208) | 0.402 |
| Female | ||||||
| Normal IVSd | 74/2169 | Reference | / | 29/2214 | Reference | / |
| IVS hypertrophy | 17/208 | 1.870 (1.062–3.292) | 0.030 | 12/213 | 3.063 (1.449–6.474) | 0.003 |
Adjusted for Sex, Age, DM, BMI, Current_smoke, Current_drink, FamilyHis, Mean_SBP, Mean_DBP, GLU, LDL_C, HDL_C as appropriate. Abbreviations: CHD, coronary heart disease; MI, myocardial infarction; IVSd, interventricular septum thickness; IVS hypertrophy, interventricular septum hypertrophy.